![Duane M. Linstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Duane M. Linstrom
Conseiller Juridique Général chez
Hirok, Inc.
Profil
Duane M.
Linstrom is currently the General Counsel at Hirok, Inc. He previously worked as Legal Counsel at Canopus Biopharma, Inc. and as Secretary at Taxus Cardium Pharmaceuticals Group, Inc.
Postes actifs de Duane M. Linstrom
| Sociétés | Poste | Début |
|---|---|---|
Hirok, Inc.
 Hirok, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and sells light weight portable cranes | Conseiller Juridique Général | 20/04/2009 |
Anciens postes connus de Duane M. Linstrom
| Sociétés | Poste | Fin |
|---|---|---|
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Secrétaire Général | - |
| BLUE HEAVEN COFFEE, INC | Conseiller Juridique Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Hirok, Inc.
Hirok, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and sells light weight portable cranes | Producer Manufacturing |
Canopus Biopharma, Inc.
 Canopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the areas of antivirals, radiation protection, cancer therapies, camelidae blood products and bio-barcode assay technologies | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
